Compounds and compositions for the treatment of conditions associated with lpa receptor activity.

CL202601304A1Pending Publication Date: 2026-08-14LHOTSE BIO INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CL202601304
Authority / Receiving Office: CL · CL
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2023-02-25
Filing Date: 2026-04-22
Publication Date: 2026-08-14

Application Information

Patent Timeline

25 Feb 2023

Priority

22 Apr 2026

Application

CL202601304

14 Aug 2026

Publication

CL202601304A1

IPC: A61P11/00; A61K31/192; A61K31/196; A61K31/351; A61K31/36; A61K31/397; A61K31/4433; A61P35/00; A61P37/00; C07C59/13; C07C59/72; C07C61/39; C07C229/18; C07C229/28; C07C229/48; C07D205/04; C07D211/66; C07D213/65; C07D309/14; C07D317/50; C07D317/54; C07D317/58; C07D401/12; C07D405/12; C07D407/12

CPC: C07D309/14; C07D317/50; C07D205/04; C07D211/66; C07D407/12; C07D401/12; C07D405/12; C07D213/65

Inventors: ZHANG Haizhen; HUANG Wei

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

This disclosure provides information on LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein. Methods for treating diseases, disorders, and conditions associated with LPA are also provided.

Need to check novelty before this filing date? Find Prior Art